Augustine Therapeutics' leadership team will be attending 16th European Life Science CEO Forum in Zurich, Switzerland

Sylvain Celanire, CEO and Christophe Van Vaeck, CFO will be attending the 16th European Life Science CEO Forum in Zurich, Switzerland on the 1st and 2nd of March 2023.

We will be sharing the latest development on our lead program targeting HDAC6 aiming at preventing and reversing axonal degeneration, restoring muscle reinnervation in neuromuscular disorders such as Charcot-Marie-Tooth disease and other axonopathies.

Agenda of SACHS Conference: 16th ELSF Forum Showcases (sachsforum.com)

Contact us: info@augustinetx.com

thinline.be | soon production